AllSquare Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-66
| Closed | -$69.4K | – | 548 |
|
|
2024
Q3 | $69.4K | Buy |
66
+6
| +10% | +$6.68K | 0.04% | 181 |
|
|
2024
Q2 | $63.1K | Hold |
60
| – | – | 0.04% | 185 |
|
|
2024
Q1 | $57.7K | Hold |
60
| – | – | 0.03% | 199 |
|
|
2023
Q4 | $52.7K | Buy |
60
+5
| +9% | +$4.12K | 0.03% | 206 |
|
|
2023
Q3 | $45.3K | Buy |
55
+26
| +90% | +$20.4K | 0.03% | 205 |
|
|
2023
Q2 | $21.1K | Buy |
+29
| New | +$22.4K | 0.01% | 292 |
|
|
2021
Q3 | – | Sell |
-14
| Closed | -$8K | – | 503 |
|
|
2021
Q2 | $8K | Hold |
14
| – | – | ﹤0.01% | 409 |
|
|
2021
Q1 | $7K | Hold |
14
| – | – | ﹤0.01% | 403 |
|
|
2020
Q4 | $7K | Sell |
14
-28
| -67% | -$15.1K | ﹤0.01% | 372 |
|
|
2020
Q3 | $24K | Buy |
42
+18
| +75% | +$10.9K | 0.02% | 254 |
|
|
2020
Q2 | $15K | Buy |
24
+9
| +60% | +$5.11K | 0.01% | 289 |
|
|
2020
Q1 | $7K | Sell |
15
-50
| -77% | -$20.6K | 0.01% | 339 |
|
|
2019
Q4 | $24K | Hold |
65
| – | – | 0.02% | 247 |
|
|
2019
Q3 | $18K | Hold |
65
| – | – | 0.01% | 266 |
|
|
2019
Q2 | $20K | Hold |
65
| – | – | 0.01% | 266 |
|
|
2019
Q1 | $27K | Hold |
65
| – | – | 0.02% | 243 |
|
|
2018
Q4 | $24K | Hold |
65
| – | – | 0.02% | 237 |
|
|
2018
Q3 | $26K | Hold |
65
| – | – | 0.02% | 243 |
|
|
2018
Q2 | $22K | Sell |
65
-40
| -38% | -$12.5K | 0.02% | 265 |
|
|
2018
Q1 | $36K | Hold |
105
| – | – | 0.03% | 174 |
|
|
2017
Q4 | $39K | Buy |
105
+35
| +50% | +$14.2K | 0.03% | 164 |
|
|
2017
Q3 | $31K | Sell |
70
-13
| -16% | -$6.19K | 0.03% | 188 |
|
|
2017
Q2 | $41K | Sell |
83
-15
| -15% | -$6.56K | 0.04% | 81 |
|
|
2017
Q1 | $38K | Sell |
98
-16
| -14% | -$5.93K | 0.03% | 154 |
|
|
2016
Q4 | $42K | Hold |
114
| – | – | 0.04% | 148 |
|
|
2016
Q3 | $46K | Sell |
114
-90
| -44% | -$36.1K | 0.04% | 128 |
|
|
2016
Q2 | $71K | Sell |
204
-9
| -4% | -$3.47K | 0.07% | 95 |
|
|
2016
Q1 | $77K | Sell |
213
-30
| -12% | -$12.4K | 0.08% | 91 |
|
|
2015
Q4 | $132K | Sell |
243
-12
| -5% | -$6.5K | 0.13% | 63 |
|
|
2015
Q3 | $119K | Hold |
255
| – | – | 0.12% | 65 |
|
|
2015
Q2 | $130K | Sell |
255
-15
| -6% | -$7.32K | 0.12% | 70 |
|
|
2015
Q1 | $122K | Sell |
270
-70
| -21% | -$29.7K | 0.12% | 75 |
|
|
2014
Q4 | $139K | Buy |
+340
| New | +$134K | 0.14% | 64 |
|
Other funds holding REGN
AllSquare Wealth Management's REGN Position: Q4 2024 in Review
AllSquare Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 66 shares — an estimated $69.4K sold.
AllSquare Wealth Management first reported a position in REGN in Q4 2014 and held it in 33 quarters. The position peaked at $139K in Q4 2014. 1,320 funds tracked by Wall St. Rank hold REGN as of Q4 2024.
- AllSquare Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
- AllSquare Wealth Management sold 66 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $69.4K.
- AllSquare Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 33 quarters.
- AllSquare Wealth Management's Regeneron Pharmaceuticals position peaked at $139K in Q4 2014.
- 1,320 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.
Based on AllSquare Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.